These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31860249)

  • 21. Washington Brings Renewed Focus to Payment Models of the Future.
    Finerfrock B; Baugh N
    Radiol Manage; 2016; 38(3):10-1. PubMed ID: 27514104
    [No Abstract]   [Full Text] [Related]  

  • 22. Toward an Integrated Federal Health System.
    Khullar D; Chokshi DA
    JAMA; 2016 Jun; 315(23):2521-2. PubMed ID: 27123569
    [No Abstract]   [Full Text] [Related]  

  • 23. Recent legislation changes the economics of cancer care.
    Silberman G; Downs CG
    ONS News; 2005 Jul; 20(7):9. PubMed ID: 16045235
    [No Abstract]   [Full Text] [Related]  

  • 24. US Cancer Care System Ill-Equipped to Deliver New Advances to Patients.
    Rappaport M
    J Oncol Pract; 2016 May; 12(5):397. PubMed ID: 27170686
    [No Abstract]   [Full Text] [Related]  

  • 25. Seeking value as cancer drug costs soar.
    Bender E
    Cancer Discov; 2013 Aug; 3(8):833-4. PubMed ID: 23928760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value and payment for oncology in the United States.
    Robinson JC
    Ann Pharm Fr; 2013 Sep; 71(5):285-90. PubMed ID: 24075699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Many new cancer drugs in the United Kingdom are facing negative NICE rulings.
    Low E;
    J Clin Oncol; 2007 Jun; 25(18):2635-6; author reply 2637-8. PubMed ID: 17577049
    [No Abstract]   [Full Text] [Related]  

  • 28. Managed care & medical oncology: the focus is on value.
    Danielson E; Demartino J; Mullen JA
    J Natl Compr Canc Netw; 2010 Sep; 8 Suppl 7():S28-37. PubMed ID: 20947721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From the editor-in-chief: lead, follow, or get out of the way.
    Alvarnas J
    Am J Manag Care; 2019 Dec; 25(12 Spec No.):SP344. PubMed ID: 31860248
    [No Abstract]   [Full Text] [Related]  

  • 30. Navigating the business of oncology for 2008.
    Crisafulli T
    Semin Oncol; 2008 Feb; 35(1):1-5. PubMed ID: 18308138
    [No Abstract]   [Full Text] [Related]  

  • 31. Perspectives on Cost and Value in Cancer Care.
    Saltz LB
    JAMA Oncol; 2016 Jan; 2(1):19-21. PubMed ID: 26501848
    [No Abstract]   [Full Text] [Related]  

  • 32. Paying for value: replacing Medicare's sustainable growth rate formula with incentives to improve care.
    Guterman S; Zezza MA; Schoen C
    Issue Brief (Commonw Fund); 2013 Mar; 16():1-10. PubMed ID: 23547336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The new Medicare bill: far-reaching effects on cancer treatment.
    Bailes JS; Coleman T
    Clin Adv Hematol Oncol; 2004 May; 2(5):292-4. PubMed ID: 16163195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer care value-learning from others.
    Gamble RB
    Am J Manag Care; 2012 May; 18(3 Spec No.):SP139. PubMed ID: 22642284
    [No Abstract]   [Full Text] [Related]  

  • 35. Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries.
    Wilking N; Bucsics A; Kandolf Sekulovic L; Kobelt G; Laslop A; Makaroff L; Roediger A; Zielinski C
    ESMO Open; 2019; 4(6):e000550. PubMed ID: 31798977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing Medicare's Approach To Covering New Drugs In Bundled Payments For Oncology.
    Muldoon LD; Pelizzari PM; Lang KA; Vandigo J; Pyenson BS
    Health Aff (Millwood); 2018 May; 37(5):743-750. PubMed ID: 29733731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring the Value of New Medications and Implications for Medicare's Proposed Part B Drug Payment Model.
    Hwang TJ; LaMattina JL
    JAMA Oncol; 2016 Sep; 2(9):1125-6. PubMed ID: 27388928
    [No Abstract]   [Full Text] [Related]  

  • 38. Medicare and drug pricing.
    Iglehart JK
    N Engl J Med; 2003 Apr; 348(16):1590-7. PubMed ID: 12700381
    [No Abstract]   [Full Text] [Related]  

  • 39. Provider perspective: Kashyap Patel, MD, sees collaboration going into Oncology Care First.
    Am J Manag Care; 2019 Dec; 25(12 Spec No.):SP378-SP379. PubMed ID: 31860252
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel approaches to delivering value in oncology drugs.
    Miller S
    Clin Adv Hematol Oncol; 2016 Apr; 14(4):244-6. PubMed ID: 27166606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.